Avalo Therapeutics Inc (NYSE: AVTX) — Healthcare · Share Price, Chart & Market Data
About: Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Wayne, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $14.40 (+3.45%)
AVTXAvalo Therapeutics Inc
Loading watchlist status…
Trade AVTX now
Avalo Therapeutics Inc share price
AVTX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:15 pm GMT+0
AVTX price performance
0.77%
5D
3.672%
1M
-15.394%
YTD
204.44%
1Y
AVTX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:15 pm GMT+0
AVTX details
AVTX Market Signals